ACLA CHALLENGES FDA'S FINAL RULE TO REGULATE LABORATORY DEVELOPED TESTING SERVICES AS MEDICAL DEVICES
May 30, 2024
May 30, 2024
WASHINGTON, May 30 -- The American Clinical Laboratory Association issued the following news release on May 29, 2024:
Today the American Clinical Laboratory Association (ACLA) and its member company, HealthTrackRx, filed a lawsuit against the U.S. Food and Drug Administration (FDA) in the United States District Court for the Eastern District of Texas, challenging the Agency's May 6, 2024, Final Rule, which inappropriately seeks to regulate professional laboratory testing services as . . .
Today the American Clinical Laboratory Association (ACLA) and its member company, HealthTrackRx, filed a lawsuit against the U.S. Food and Drug Administration (FDA) in the United States District Court for the Eastern District of Texas, challenging the Agency's May 6, 2024, Final Rule, which inappropriately seeks to regulate professional laboratory testing services as . . .